Finally, given that neither the LRRK2 G2019S nor GCase N370S mutations are fully penetrant, it is not surprising to find heterogeneity across patient lines, and the ongoing study of additional lines will help to clarify the extent of heterogeneity of these important PD mutations. Here, LRRK2 is linked to Parkinson disease.